Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-4 of 4 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Apixaban for reduction in stroke and other ThromboemboLic events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationaleLopes, R.; Alexander, J.; Al-Khatib, S.; Ansell, J.; Diaz, R.; Easton, J.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Hylek, E.; McMurray, J.; Verheugt, F.; Wallentin, L.
2012Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialLopes, R.; Al-Khatib, S.; Wallentin, L.; Yang, H.; Ansell, J.; Bahit, M.; De Caterina, R.; Dorian, P.; Easton, J.; Erol, C.; Ezekowitz, J.; Gersh, B.; Granger, C.; Hohnloser, S.; Horowitz, J.; Hylek, E.; McMurray, J.; Mohan, P.; Vinereanu, D.; Alexander, J.
2014Response to letter regarding article, "efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation"Wallentin, L.; Lopes, R.D.; Hanna, M.; Thomas, L.; Hellkamp, A.; Nepal, S.; Hylek, E.M.; Al-Khatib, S.M.; Alexander, J.H.; Alings, M.; Amerena, J.; Ansell, J.; Aylward, P.; Bartunek, J.; Commerford, P.; De Caterina, R.; Erol, C.; Harjola, V.P.; Held, C.; Horowitz, J.; et al.
2014D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trialChristersson, C.; Wallentin, L.; Andersson, U.; Alexander, J.; Ansell, J.; De Caterina, R.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Huber, K.; Husted, S.; Hylek, E.; Lopes, R.; Siegbahn, A.